US Stock Movement | Vertex Pharmaceuticals (VRTX.US) surges after hours as late-stage trial of kidney drug povetacicept meets expected targets
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Previously, this biotechnology company announced that its drug for treating kidney disease met the expected targets in late-stage trials, injecting momentum into its strategy to go beyond cystic fibrosis treatments. As of Monday's close, the company's stock price has risen 1.7% so far this year.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Brian Armstrong says Bitcoin will become the global reserve currency
AiCoin•2026/08/16 22:16
Atari converts IRATA loans into 428,649 shares at EUR 24 each
Reuters•2026/08/16 21:35
Ramsay Health Care opens $16 million day hospital in Cleveland, Queensland
Reuters•2026/08/16 21:24
Mercury appoints Summerset CEO Scott Scoullar as director
Reuters•2026/08/16 20:39
Crypto prices
MoreBitcoin
BTC
$62,878.16
-0.30%
Ethereum
ETH
$1,874.38
-0.42%
Tether USDt
USDT
$0.9989
+0.01%
USDC
USDC
$0.9999
+0.00%
XRP
XRP
$0.9930
-1.01%
Solana
SOL
$74.45
-1.35%
TRON
TRX
$0.3310
-0.01%
Hyperliquid
HYPE
$57.24
+0.69%
Dogecoin
DOGE
$0.06954
-0.35%
Zcash
ZEC
$486.84
-0.20%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now